Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 4.79 is 17% above its 5-year average of 4.12, near the high end of its 5-year range (2.84–5.56).
As of the fiscal period ended Tuesday, June 30, 2026. 35.41% above its 12-month average of 3.54.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.79.
CURRENT RATIO
4.79
CURRENT RATIO AVG TTM
3.54
CURRENT RATIO AVG 3Y
3.84
CURRENT RATIO AVG 5Y
4.12
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+35.41%
CURRENT VS 3Y AVG
+25.01%
CURRENT VS 5Y AVG
+16.51%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.04
median of 420 covered companies
CURRENT VS SECTOR MEDIAN
+57.47%
vs the sector median at left
Adaptive Biotechnologies Corporation
Market Cap
$4.78B
Current Ratio
4.79
TTM Avg
3.54
3Y Avg
3.84
5Y Avg
4.12
Market Cap
$4.81B
Current Ratio
6.95
TTM Avg
6.77
3Y Avg
6.23
5Y Avg
10.87
Market Cap
$4.92B
Current Ratio
26.10
TTM Avg
14.27
3Y Avg
14.23
5Y Avg
14.47
Market Cap
$4.50B
Current Ratio
5.08
TTM Avg
3.83
3Y Avg
4.06
5Y Avg
4.06
Market Cap
$5.20B
Current Ratio
7.02
TTM Avg
8.28
3Y Avg
8.59
5Y Avg
7.77
Market Cap
$5.20B
Current Ratio
4.20
TTM Avg
4.30
3Y Avg
4.12
5Y Avg
3.47
Market Cap
$4.34B
Current Ratio
16.24
TTM Avg
19.89
3Y Avg
20.20
5Y Avg
22.94
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adaptive Biotechnologies Corporation (ADPT) | $4.78B | 4.79 | 3.54 | 3.84 | 4.12 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.81B | 6.95 | 6.77 | 6.23 | 10.87 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.92B | 26.10 | 14.27 | 14.23 | 14.47 |
| BillionToOne, Inc. (BLLN)vs › | $5.02B | 11.69 | 9.86 | 7.15 | 7.15 |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.50B | 5.08 | 3.83 | 4.06 | 4.06 |
| Erasca, Inc. (ERAS)vs › | $5.11B | 8.29 | 9.94 | 10.32 | 11.01 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.20B | 7.02 | 8.28 | 8.59 | 7.77 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.20B | 4.20 | 4.30 | 4.12 | 3.47 |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.34B | 16.24 | 19.89 | 20.20 | 22.94 |
| Cogent Biosciences, Inc. (COGT)vs › | $5.27B | 13.57 | 9.78 | 9.13 | 11.38 |
Current Ratio
4.79
Quick Ratio
4.68
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 4.79 |
| 2026-03-31 | 3.35 |
| 2025-12-31 | 3.34 |
| 2025-09-30 | 3.38 |
| 2025-06-30 | 2.84 |
| 2025-03-31 | 2.92 |
| 2024-12-31 | 2.89 |
| 2024-09-30 | 3.52 |
| 2024-06-30 | 3.99 |
| 2024-03-31 | 4.51 |
| 2023-12-31 | 4.66 |
| 2023-09-30 | 4.67 |
| 2023-06-30 | 5.00 |
| 2023-03-31 | 5.56 |
| 2022-12-31 | 5.12 |
| 2022-09-30 | 5.43 |
| 2022-06-30 | 3.93 |
| 2022-03-31 | 3.64 |
| 2021-12-31 | 3.54 |
| 2021-09-30 | 3.82 |
| 2021-06-30 | 5.52 |
| 2021-03-31 | 7.16 |
| 2020-12-31 | 6.91 |
| 2020-09-30 | 8.70 |
| 2020-06-30 | 6.42 |
| 2020-03-31 | 7.50 |
| 2019-12-31 | 7.82 |
| 2019-09-30 | 8.20 |
| 2019-06-30 | 5.91 |
| 2019-03-31 | 7.26 |
| 2018-12-31 | 7.93 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
